Walleye Trading’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-63,000
Closed -$3.53K 5723
2023
Q3
$3.53K Buy
63,000
+45,000
+250% +$5.38K ﹤0.01% 4676
2023
Q2
$2.65K Hold
18,000
﹤0.01% 4449
2023
Q1
$1.71K Hold
18,000
﹤0.01% 4674
2022
Q4
$1.8K Hold
18,000
﹤0.01% 4743
2022
Q3
$1K Hold
18,000
﹤0.01% 4911
2022
Q2
$3K Hold
18,000
﹤0.01% 4901
2022
Q1
$4K Buy
+18,000
New +$4.67K ﹤0.01% 5153

Walleye Trading's BIOSW Position: Q4 2023 in Review

Walleye Trading sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 63,000 shares — an estimated $3.53K sold.

Walleye Trading first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Walleye Trading reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 63,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $3.53K.
  • Walleye Trading first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Walleye Trading's BioPlus Acquisition Corp. Warrants position peaked at $4K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.